Adenoid hypertrophy is a common and frequently occurring disease in the field of otolaryngology head and neck surgery. Clinically, adenoid hypertrophy is mainly treated through surgical removal, which is typically performed under endoscopic guidance using techniques such as plasma surgery.

As for its clinical drug treatment, it should be noted first that there are no drugs specifically targeting adenoid hypertrophy. The drugs currently used, such as mometasone furoate nasal spray and montelukast sodium, are aimed at treating allergic factors related to adenoid hypertrophy. These drugs have some effects, but their efficacy is relatively poor, and only a small portion of patients achieve certain therapeutic effects.

Therefore, if adenoid hypertrophy causes secondary diseases such as snoring, otitis media, or sinusitis in patients, it is still necessary to proceed with active surgical treatment.

(Specific medications should be used under the guidance of a physician)